Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioscience Animal Health PCLBKK:BIS -0.89%83 PS Ratio is 0.32 as of Jul. 21, 2026, which is 29% below its 10-year median of 0.45. GuruFocus rates BKK:BIS with a GF Score™ of 83/100 and a GF Value™ of ฿2.86 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,943 Consumer Packaged Goods companies, Bioscience Animal Health PCL ranks better than 79.93% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Bioscience Animal Health PCL's share price is ฿2.22.
Bioscience Animal Health PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿7.01. Hence, Bioscience Animal Health PCL's PS Ratio for today is 0.32.
The historical rank and industry rank for Bioscience Animal Health PCL's PS Ratio or its related term are showing as below:
BKK:BIS'
s PS Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.45 Max: 1.82
Current: 0.32
During the past 9 years, Bioscience Animal Health PCL's highest PS Ratio was 1.82. The lowest was 0.26. And the median was 0.45.
BKK:BIS's PS Ratio is ranked better than 79.93% of 1943
companies
in the Consumer Packaged Goods industry
Industry Median: 0.86
vs BKK:BIS: 0.32
During the past 9 years, Bioscience Animal Health PCL's highest 3-Year average Revenue per Share Growth Rate was 77.60% per year. The lowest was -2.50% per year. And the median was 10.15% per year.
Back to Basics: PS Ratio
Bioscience Animal Health PCL (BKK:BIS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Bioscience Animal Health PCL PS Ratio Related Terms
Bioscience Animal Health PCL PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Bioscience Animal Health PCL's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioscience Animal Health PCL PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's PS Ratio distribution charts can be found below:
* The bar in red indicates where Bioscience Animal Health PCL's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Bioscience Animal Health PCL's Share Price of today is ฿2.22. Bioscience Animal Health PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿7.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Bioscience Animal Health PCL (BKK:BIS) has a PS Ratio of 0.32 as of Jul. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Bioscience Animal Health PCL and its competitors. This is 29% below median its historical median of 0.45. Over the past decade, Bioscience Animal Health PCL's PS Ratio has ranged from 0.26 to 1.82. According to the industry distribution chart, Bioscience Animal Health PCL ranks #390 out of 1943 companies in the Consumer Packaged Goods industry, placing it in the top 20.1%.
Is Bioscience Animal Health PCL's PS Ratio too high?
Bioscience Animal Health PCL's current PS Ratio of 0.32 is 29% below median its 10-year median of 0.45. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 1.82. The Consumer Packaged Goods industry median PS Ratio is 0.86. Bioscience Animal Health PCL's value of 0.32 is 62.8% below this industry median. Based on the distribution chart, Bioscience Animal Health PCL ranks #390 out of 1943 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Bioscience Animal Health PCL has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioscience Animal Health PCL's PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioscience Animal Health PCL ranks #390 out of 1943 companies for PS Ratio. This places Bioscience Animal Health PCL in the top 20% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.86. Bioscience Animal Health PCL's value of 0.32 is 62.8% below this benchmark. Historically, Bioscience Animal Health PCL's own PS Ratio has ranged from 0.26 to 1.82 over the past decade. While the company's 10-year median is 0.45 vs. the industry median of 0.86, Bioscience Animal Health PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.86, based on 1,943 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioscience Animal Health PCL's current PS Ratio of 0.32 is 62.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Bioscience Animal Health PCL and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioscience Animal Health PCL's current PS Ratio is 0.32, which is 29% below median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioscience Animal Health PCL stock overvalued right now?
Based on GuruFocus' analysis, Bioscience Animal Health PCL (BKK:BIS) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.86, compared to a current price of ฿2.22 — trading 22.4% below its estimated fair value. The current PS Ratio is 0.32, which is 29% below median its 10-year median of 0.45 and 62.8% below the Consumer Packaged Goods industry median of 0.86. Bioscience Animal Health PCL's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Bioscience Animal Health PCL (BKK:BIS), the current PS Ratio is 0.32 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioscience Animal Health PCL (BKK:BIS) Overvalued in 2026?
Based on GuruFocus' analysis, Bioscience Animal Health PCL stock appears to be undervalued.
The current stock price of ฿2.22 is trading 22.4% below its estimated GF Value™ of ฿2.86.
GuruFocus considers Bioscience Animal Health PCL to be Modestly Undervalued.
Key valuation signals for BKK:BIS:
PS Ratio: 0.32 (29% below median its 10-year median of 0.45)
GF Value™: ฿2.86 vs. price of ฿2.22 (22.4% below fair value)
Industry Position: 62.8% below the Consumer Packaged Goods median (#390 of 1943)
No single metric tells the full story. See the BKK:BIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
83GF Score
Get the complete analysis for BKK:BIS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BIS has been successfully added to your 
